Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy (2008)
- Authors:
- USP affiliated authors: LEOPOLDINO, ANDRÉIA MACHADO - FCFRP ; SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- Subjects: MÉTODO DE MONTE CARLO; RAIOS X
- Language: Inglês
- Imprenta:
- Source:
- Título: Program
- Conference titles: Annual Meeting of the American Association of Physicists in Medicine (AAPM)
-
ABNT
SILVA, Carlos Henrique Tomich de Paula da e NAMBA, Adriana M. e LEOPOLDINO, Andréia Machado. Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy. 2008, Anais.. Houston: AAPM, 2008. . Acesso em: 06 fev. 2026. -
APA
Silva, C. H. T. de P. da, Namba, A. M., & Leopoldino, A. M. (2008). Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy. In Program. Houston: AAPM. -
NLM
Silva CHT de P da, Namba AM, Leopoldino AM. Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy. Program. 2008 ;[citado 2026 fev. 06 ] -
Vancouver
Silva CHT de P da, Namba AM, Leopoldino AM. Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy. Program. 2008 ;[citado 2026 fev. 06 ] - In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds
- Análise comparativa do perfil metabólico de fibroblastos do estroma de CEC oral e de fibroblastos de mucosa oral normal
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
- Current topics in computer-aided drug design
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- General aspects of lead finding and optimization in drug discovery
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
